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Abstract
Hirschsprung’s disease (HSCR) is a rare congenital disease caused by impaired proliferation and migration of neural crest cells. We investigated
changes in expression of microRNAs (miRNAs) and the genes they regulate in tissues of patients with HSCR. Quantitative real-time PCR and
immunoblot analyses were used to measure levels of miRNA, mRNAs, and proteins in colon tissues from 69 patients with HSCR and 49 individ-
uals without HSCR (controls). Direct interactions between miRNAs and specific mRNAs were indentified in vitro, while the function role of miR-
218-1 was investigated by using miR-218 transgenic mice. An increased level of miR-218-1 correlated with increased levels of SLIT2 and
decreased levels of RET and PLAG1 mRNA and protein. The reductions in RET and PLAG1 by miR-218-1 reduced proliferation and migration of
SH-SY5Y cells. Overexpression of the secreted form of SLIT2 inhibited cell migration via binding to its receptor ROBO1. Bowel tissues from
miR-218-1 transgenic mice had nerve fibre hyperplasia and reduced numbers of gangliocytes, compared with wild-type mice. Altered miR-218-
1 regulation of SLIT2, RET and PLAG1 might be involved in the pathogenesis of HSCR.
Keywords: intestine gene regulation neural development genetic disorder
Introduction
Hirschsprung’s disease (HSCR) is a gastrointestinal disorder with an
incidence of 1:200–1:5000 live births, with males being four times
more affected than females in short segment HSCR [1]. It is charac-
terized that the enteric neural crest cells (ENCCs) stop migrating and
fail to reach the hindgut during embryogenesis from 5 to 12 weeks,
which leads to the absence of ganglia cells in the intramural and sub-
mucosal along variable lengths of gastrointestinal tract [2]. The aetio-
logical studies of HSCR have shown that the development of disease
is a complicated process involving both genetic factors and environ-
mental conditions [3]. In particular, genes controlling ENCC migration
play important roles in the pathogenesis of HSCR [4]. It is known that
the ENCCs in the distal rectum migrate further than any other cells
during embryogenesis. Thus, any aberration of survival, proliferation,
migration or differentiation of ENCCs will result in aganglionosis of
the distal gut [5]. To date, more than 10 genes have been identified to
be associated with the pathogenesis of HSCR [6]. RET proto-onco-
gene known as tyrosine kinase receptor, is widely expressed in neural
crest cell, endocrine system and urinogenital system [6]. RET protein
is crucial for the development of enteric neuron cells. Some evidence
have shown that mutations that lead to a reduction of RET expression
could result in HSCR [7]. Furthermore, it has been reported that RET
is associated with neural cell migration [8].
MiRNAs are small, non-coding RNA molecules of 19–25 nucleo-
tides which have been reported to play important roles by regulating
cell differentiation, proliferation, migration and apoptosis [9]. miRNAs
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negatively regulate their target genes expression at the post-
transcription level through binding to 30 untranslated regions (UTRs)
of their targets message RNAs [10]. To date, more than 800 miRNAs
have been identified in mammalian cells [11]. Many of them have also
been implicated in cancer development and metastasis [12]. In addi-
tion, certain miRNAs have been found in the central neural system
during embryonic development [13]. However, to our knowledge, the
role of miRNAs in HSCR disease is not known yet.
miRNAs are transcribed in parallel with their host transcripts, and
the two different transcription classes of miRNAs (‘exonic’ and ‘intron-
ic’) identified have been reported to play important roles in the patho-
genesis of different diseases [14]. For example, the expression level of
miR-126 was directly controlled by its host gene EGFL7 through epi-
genetic changes [15]. miR-103 and miR-107, hosted by pantothenate
kinase genes, are proposed to regulate cellular lipid metabolism [16].
So far, few miRNAs and their related host genes are observed to be
involved in embryonic peripheral nervous system development,
especially in the enteric nervous system (ENS) development.
Slit homologue 2/Roundabout homologue 1(SLIT2/ROBO1) path-
way is closely related with cell migration [17]. Along with an evolu-
tionary conserved role in axon guidance, SLIT2/ROBO1 pathway has
a key function in nervous system, especially in neural crest cell migra-
tion [18]. The full length of the secreted protein SLIT2 can be cleaved
into two smaller fragments, a 140 kD N-terminal product (N-SLIT2)
and a 50–60 kD C-terminal product (C-SLIT2). N-SLIT2 is the frag-
ment responsible to bind ROBO1, a single-pass transmembrane
receptor of SLIT2 [19]. In this study, we began our study based on
the potential miRNA regulating RET in HSCR by bioinformatics
prediction. The results indicated that miR-218-1 was the top one miR-
NA, thus, we investigated the roles of miR-218-1, SLIT/ROBO1 in
HSCR disease development by using human tissues, cells and a
transgenic mice model.
Materials and methods
Ethics statement and samples collection
This study was approved by the Institutional Ethics Committee of Nanj-
ing Medical University, and it was performed under compliance with the
government policies and the Helsinki Declaration. Both HSCR and con-
trol group samples were collected after informed consent was obtained
from their guardians. A total of 69 HSCR colon tissues were obtained
from HSCR patients who had acquired surgical treatment in Nanjing
Children’s Hospital Affiliated to Nanjing Medical University from October
2009 to May 2012 (NJMU Birth Cohort). The 69 patients in our study
consisted of 42 short segment patients and 27 long segment patients.
All the patients were diagnosed by barium enema and anorectal
manometry evaluation before surgical procedures. After surgery, patho-
logical analysis was performed for definite diagnosis. Colon tissues of
49 controls were obtained from isolated patients that received surgical
treatment because of intussusception or incarcerated and strangulated
inguinal hernia without the ischaemia or necrosis. These patients did
not have HSCR or other congenital malformation. All tissues collected
were immediately frozen and stored at 80°C after surgery.
Quantitative RT-PCR
Quantitative real-time polymerase chain reaction (qRT-PCR) was per-
formed to determine the expression levels of miR-218-1 and mRNAs of all
related genes. Total RNA was obtained from tissues using TRIzol reagent
as described by the manufacturer (Invitrogen Life Technologies, Carlsbad,
CA, USA). For mRNA detection, total RNAs (500 ng) were reverse tran-
scribed using the reverse transcription kit (Takara, Tokyo, Japan). b-actin
was used as an internal control. TaqManMicroRNA Assays ( Applied Bio-
systems, Foster City, CA, USA) was used as the probe for has-miR-218-1
and has-U6 which act as a normalized control. All the primer sequences
are shown in Table S1. qRT-PCR was performed with ABI Prism 7900HT
(Applied Biosystems) according to the manufacturer’s instructions.
Bioinformatics prediction
The method we used to predict the related potentially target RET was
according to the prediction of the bioinformatical software online includ-
ing Target Scan (www.targetscan.org), PicTar (pictar.mdc-berlin.de/)
and miRNA.org (http://www.microrna.org/).
Protein analysis
For Western blotting, total proteins were extracted from tissues or cul-
tured cells using RIPA buffer containing protease inhibitors cOmplete,
ULTRA, Mini, EDTA-free, EASYpack (Roche, Basel, Switzerland), while
the membrane proteins were extracted from tissues by Mem-PER Eukary-
otic Membrane Protein Extraction Reagent Kit (Thermo Scientific, Rock-
ford, IL, USA). Equal amount of proteins (100 lg) were separated with
7.5%/12.5% SDS-PAGE and transferred to polyvinylidene fluoride mem-
brane. Primary polyclonal antibodies including RET antibody (SC167),
PLAG1 antibody (SC20320), SLIT2 antibody (SC26601) and ROBO1 anti-
body (SC16612) were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). The secondary antibodies were anti-rabbit or anti-goat
HRP-linked were purchased from Santa Cruz Biotechnology. The blots
were developed using ECL reagent (Millpore, Billerica, MA, USA). Equal
amount of protein loading in each lane was confirmed using GAPDH anti-
body. The integrated density of the band was quantified by Image J soft-
ware (National Institute of Mental Health, Bethesda, Maryland, USA).
Cell culture and reagents
Human SH-SY5Y cell were obtained from American Type Culture Collec-
tion (ATCC, Manassas, VA, USA), and were cultured in DMEM (HyClone,
Logan, UT, USA), supplemented with 10% foetal bovine serum, 100 U/ml
penicillin, and 100 lg/ml streptomycin at 37°C, 5% CO2. Synthetic miRNA
precursor molecules of miR-218-1, siRNA of ROBO1 and negative control
(GenePharma, Shanghai, China) were used in transfection experiments.
Cells were treated with or without recombinant SLIT2-N protein (Pepro-
tech, Rocky Hill, NJ, USA) at final concentrations of 100 ng/ml.
Cell proliferation assays
Cell proliferation was assayed using EdU (5-Ethynyl-20-deoxyuridine;
Roche). EDU (Ribobio, Guangzhou, China) assay was used to examine
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the cell proliferation. Fluorescence staining was determined using a con-
focal microscope (Olympus, Tokyo, Japan). Each assay was performed
in triplicate and repeated three times independently.
Cell cycle and apoptosis analysis
Cells were transfected with miR-218 mimics as well as negative controls
or treated with SLIT2-N for 48 hrs. All experiments were analysed by BD
Biosciences FACS Calibur Flow Cytometry (BD Bioscience Pharmingen
Inc., San Diego, CA, USA). The tests were repeated for three times with
triplicate per experiment.
Cell transwell assays
For those cells treated with miRNA or siRNA, after transfection for
48 hrs, cells were seeded at 1 9 106 cells/ml with serum-free medium.
For the cells treated with SLIT2-N, after 48 hrs treatment, 100 ll cell
suspension with serum-free medium was seeded to the upper chamber,
cells were stained with crystal violet staining solution (Beyotime, Nan-
tong, China) then counted and photographed under 409 magnification
(five views per well). Migrated cells were counted by using Image-pro
Plus 6.0 while cell numbers of normal control group were normalized to
1. The integrated intensity of migrated cells was measured by MetaMor-
ph/MetaXpress as well. All experiments were performed in triplicate.
Dual-luciferase reporter assay
The 30 UTR sequence of RET and PLAG1 predicted to interact with
miR-218 or a mutated sequence with the predicted target sites were
inserted into the KpnI and SacI sites of pGL3 promoter vector (Gen-
script, Nanjing, China). These constructs were named pGL3-RET, pGL3-
PLAG1 and pGL3-RET-mut. For reporter assay, cells were plated onto
24-well plates and transfected with 100 ng of pGL3-RET, pGL3-PLAG1
or pGL3-RET-mut, pGL3-PLAG1-mut 50 nM miR-218-1 mimics and
control, respectively, using Lipofectamine 2000 (Invitrogen Corp). A
Renilla luciferase vector pRL-SV40 (5 ng) was also cotransfected to
normalize the differences in transfection efficiency. Transfection was
repeated three times in triplicate.
Transgenic mice
A fragment of DNA containing the precursor sequence of mmu-miR-
218-1 was amplified and subcloned into the ScaI and BamHI sites of
the pUBC CSH4 mMir218-1 constructs carrying the UBC promoter and
BGH poly(A) signal. Transgenic mice were generated by pronuclear
injection of the transgene into the C57BL/6 strain. Genomic DNA iso-
lated from the tail was analysed. The positive miR-218-1 transgenic
mice were identified by the successful PCR amplification. The detailed
primer was MIR218-EF3/BGH-R (MIR218-EF3: 50-CGAGGCAGGTCT-
TACTTGTCT-30 BGH-R: 50-AGAAGGCACAGTCGAGG-30) with a product of
480 bp under the PCR condition of 94°C for 5 min., then 35 cycles of
94°C for 30 sec., 55°C for 30 sec., and 72°C for 30 sec.; 72°C, 10 min.
The number of mice in F1 was total 83. Fifteen of 83 presented the suc-
cessful overexpression of miR-218-1. Only one presented the post-natal
death. Few mice in our study presented embryonic or post-natal lethal-
ity. The foetal gut was examined at E18.5. Adult male C57BL/6 mice
(22–25 g) were used in this study. Mice were kept under standard ani-
mal room conditions with food and water ad libitum before the experi-
mental procedures. Our experiments were approved by the Animal Care
and Use Committee of Nanjing medical university, and were performed
in accordance with the guidelines that were established by the Chinese
Association for Laboratory Animal Sciences.
Histology and immunohistochemistry
Bowel specimens were fixed in 4% paraformaldehyde, embedded in paraf-
fin, sectioned at 4 lm and mounted on silane-coated glass slides. Sec-
tions were stained with haematoxylin and eosin according to standard
protocols. Sections were deparaffinized and followed by rehydration steps
through a graded ethanol series and distilled water, and then were treated
with 3% H2O2 in methanol for 30 min to block the endogenous peroxidase
activity. The sections were rinsed in PBS twice, 5 min. each time and
incubated with 10% normal goat serum for 30 min. to block non-specific
antibody binding. After washing, the samples were incubated with primary
anti-rabbit antibody PGP9.5 (1:200, sc-25800; Santa Cruz Biotechnology)
and cathepsin D (1:200, sc-10725; Santa Cruz Biotechnology) at 4°C over-
night, and then washed in PBS for three times and then incubated with
secondary antibodies. After that, the sections were stained with DAB
according to manufacturer’s protocols and mounted and photographed
using a digitalized microscope camera (Nikon, Tokyo, Japan).
Statistical analysis
The method of 2MCt was used to analyse the results of RT-PCR in all
the experiments performed in this study. Statistical analysis was per-
formed with STATA 9.2, and presented with Graph PAD prism software.
Experimental data of tissue samples are presented as box plot of the
median and range of log-transformed relative expression level which
was analysed by Wilcoxon rank-sum (Mann–Whitney) test. The top and
bottom of the box represent the 75th and 25th percentile. The whiskers
indicate the 10th and 90th points. While the results obtained from
experiment in vitro assays are presented as mean  SEM from three
separate experiments in triplicates per experiment, and the data were
analysed by double-sided Student’s t-test. Pearson correlation analysis
was used to analyse the relationship of expression level of tissues
between case and control group. Results were considered statistically
significant at P < 0.05.
Results
Clinical information analysis
A total of 69 human HSCR colon tissue specimens collected from
HSCR patients diagnosed with HSCR disease by pathological detec-
tion were used for this study. A total of 49 normal colon tissue speci-
mens were used as controls. The clinical information, including age,
gender rate (Male/Female) and bodyweight, was obtained from both
HSCR patients and normal controls. The age of HSCR and control
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groups were 3.6  0.24 and 3.2  0.31 months old, respectively;
the bodyweight were 5.9  0.32 and 5.2  0.26 kg, both of which
had no statistical difference. The gender rate (Male/Female) of HSCR
and control was 56/13 and 40/9, respectively, which matched the
common gender rate of this disease in human beings.
RET and PLAG1 are down-regulated, whereas
miR-218-1 is up-regulated in HSCR patients
As RET was one of the most important genes related to HSCR, we
used RT-PCR and Western blotting to examine RET expression levels
in HSCR samples and control samples. RET expression levels in
HSCR samples were significantly lower than those in the controls,
P = 5.53 9 109 (Fig. 1A) which was consistent with their protein
expression levels. We used bioinformatics methods to predict related
miRNAs which potentially target RET gene. The results indicated that
only miR-218-1 was predicted to target RET by all three databases,
which prompted us to investigate the expression level of miR-218-1
in HSCR samples. Interestingly, miR-218-1 in HSCR samples were
found to be significantly higher in HSCR than in controls samples
(P = 8.02 9 108) as shown in Figure 1B, indicating that RET and
miR-218-1 might be involved in the pathological development of
HSCR disease.
We also selected another five candidate target genes of miR-218-
1 mRNA, which showed a high score in all of the bioinformatics soft-
ware described above for expression analysis (Table S1). Among the
five candidate genes predicted, only PLAG1 exhibited a decreased
mRNA level in HSCR samples compared with the control samples
(P = 1.21 9 106, see Fig. 1C). The other four genes, SLC1A2,
TMEM25, ZDHHC8 and EIF5A2, showed no statistical difference, as
indicated by P = 0.62, 0.72, 0.75, 0.74, respectively (data not
shown). Furthermore, the Western blotting assay confirmed the
down-regulation of PLAG1 in HSCR samples at protein level (Fig. 1D).
Integrated density was presented in Figure S4A.
Next, we analysed the relationship between miR-218-1 and RET
relative expression levels in patients’ samples and control samples.
An inverse correlation was observed between RET expression and
miR-218-1 expression, P = 0.003, R = 0.28 (Fig. 1E). These
results suggested that the level of RET could be regulated by miR-
218-1. Similarly, statistical analysis of the qRT-PCR results also
revealed a significant inverse correlation between the levels of PLAG1
mRNA and miR-218-1, P = 0.001, R = 0.31 (Fig. 1F), suggesting
miR-218-1 regulates both RET and PLAG1 in HSCR.
Overexpression of miR-218-1 reduced RET and
PLAG1 proteins expression resulting in inhibition
of cell proliferation and migration
To determine the effect of miR-218-1 on RET and PLAG1 expres-
sions, we overexpressed miR-218-1 in SH-SY5Y cell line. The
A
D E F
B C
Fig. 1 RET and PLAG1 are up-regulated, whereas miR-218-1 is down-regulated in HSCR patients. (A) The mRNA levels of RET in human HSCR tis-
sues (n = 69) and control tissues (n = 49) were evaluated by qRT-PCR. Data were presented as box plot of the median and range of log-trans-
formed relative expression level. The top and bottom of the box represent the 75th and 25th percentile. The whiskers indicate the 10th and 90th
points. * Significantly different compared with that of control (P < 0.05). (B) The expression levels of miR-218-1 in human HSCR tissues and con-
trol tissues. (C and D) The expression levels of RET and PLAG1 in human HSCR tissues (three representative samples from both groups are
shown). (E and F) RET and PLAG1 are down-regulated, whereas miR-218-1 is up-regulated in HSCR patients, P = 0.003, R = 0.28, P = 0.001,
R = 0.31, respectively. Data were analysed using Pearson correlation analysis with natural log-transformed expression levels.
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transfection efficiency was examined by fluorescence microscope
(Fig. S1A). As expected, overexpression of miR-218-1 decreased
RET and PLAG1 both at mRNA and protein levels (Fig. 2A). Inte-
grated density was presented in Figure S4B. To investigate
whether the inhibitory effect was because of direct binding of
miR-218-1 to the 30 UTR regions of RET and PLAG1, we per-
formed miRNA luciferase reporter assay by constructing the wild-
type and mutant type luciferase reporter plasmids containing the
binding region of the 30 UTR of RET or PLAG1 mRNAs. We
found that cotransfection of miR-218-1 mimics and pGL3-RET or
pGL3-PLAG1 30 UTR reporter plasmids significantly decreased
luciferase activity in cell lines when compared to the control
(Fig. 2B and C) suggesting that miR-128-1 directly targets both
RET and PLAG1.
As PLAG1 has been reported to be associated with cell prolifera-
tion, we further conducted the experiment to investigate the potential
role of PLAG1 in the pathogenesis of HSCR. As described above, the
expression level of PLAG1 was reduced by siRNA as confirmed in Fig-
ure S3A. The EDU assay was used to detect the proliferation in
SH-SY5Y cell line. The results showed that the proliferation ability
of cells was suppressed because of the decreased level of PLAG1
(Figure S3B).
To detect the functional roles of miR-218-1, we then examined
the effect of miR-218-1 on cell proliferation and cell migration. A sup-
pressive effect was observed in cell migration and proliferation in
SH-SY5Y cell line by using the transwell assay and EDU assay respec-
tively (Fig. 3A and B). Both the number of migrated cells and the inte-
grated intensity of migrated cells were significantly lower in miR-218-
1 overexpressing cells, suggesting that cell migration was suppressed
by miR-218-1.
SLIT2, the host gene of miR-218-1, and
SLIT2/ROBO1 pathway in HSCR
The miR-218-1 gene resides in the intron 15 (274664–274773) of
SLIT2 gene [20], which acts as the host gene of miR-218-1 (Fig. 4A).
The correlation analysis showed that a significant positive correlation
was observed between the levels of miR-218-1 and SLIT2,
P = 0.0003, R = 0.34 (Fig. 4B), indicating miR-218-1 was tran-
scribed together with its host genes SLIT2. We assessed the expres-
sion status of SLIT2 and its receptor ROBO1 in HSCR tissue samples.
As shown in Figure 4C, both SLIT2 and its receptor ROBO1 mRNAs
displayed a higher level in HSCR, P = 5.72 9 108 and
4.47 9 106, respectively. Besides, a positive correlation was
observed between SLIT2 expression and ROBO1 expression,
P = 0.03, R = 0.21 (Fig. 4C). The protein levels of SLIT2 and ROBO1
showed the same tendency as well (Fig. 4D), suggesting SLIT2/
ROBO1 pathway might also play a vital role in the pathogenesis of
HSCR. Integrated density was presented in Figure S4A.
A B
C
Fig. 2 Overexpression of miR-218-1 reduced RET and PLAG1 proteins expression. (A) SH-SY5Y cells were transfected with 50 nM miR-218 mimics
for 48 hrs. qRT-PCR was performed to evaluate the mRNA level of RET and PLAG1 (left panel). RET and PLAG1 protein expression levels were anal-
ysed by Western blotting (right panel). (B) Sequence alignment of human miR-218-1 with 30 UTR of RET or PLAG1. Bottom: mutations in the 30
UTR of RET and PLAG1 to create the mutant luciferase reporter construct. (C) Cells were cotransfected with miR-218-1 mimics or miR-control, re-
nilla luciferase vector pRL-SV40 and RET or PLAG1 30 UTR luciferase reporters for 48 hrs. Both firefly and Renilla luciferase activities are measured
in the same sample. Firefly luciferase signals were normalized with Renilla luciferase signals. * indicates significant difference compared with that of
control cells (P < 0.05). All tests were performed in triplicate and presented as mean  SE.
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Overexpression of SLIT2 suppressed cell
migration via SLIT2/ROBO1 pathway
The above results prompted us to hypothesize that SLIT2, the host
gene of miR-218-1 may also be important in the pathogenesis of
HSCR. To validate this hypothesis, we investigated the effects of
SLIT2 on cell growth, migration, apoptosis and cell cycle as well.
SLIT2 can be cleaved into Slit2-C, a diffusible fragment, and Slit2-N, a
protein tightly binding to the cell membrane to exert its function. We
applied an exogenous SLIT2-N to determine the functional effect of
SLIT2 in vitro.
EDU assays were performed to examine the effect of Slit2-N on
cell growth. After being treated with 100 ng/ml of Slit2-N for 24 hrs,
the SH-SY5Y cells showed no significant difference compared with
the control (Fig. S2A). We also evaluated the effect of SLIT2-N on
apoptosis and cell cycle. As shown in Figure S2B and C, Slit2-N treat-
ment for 24 hrs had no significant effect on cell apoptosis and cell
cycle.
Boyden chamber migration assays were used to detect the migra-
tory potential of both cells treated with recombinant SLIT2-N. As
shown in Figure 5A, the average number of migrated cells in SLIT2-
N-treated cells was significantly lower than that of the migrated con-
trol cells (P < 0.01). Moreover, the integrated intensity of migrated
cells measured by MetaMorph/MetaXpress was higher than control
cells, which was consistent with the result of cell number counting.
To analyse whether the inhibitory effect on migration by SLIT2-
N was mediated through SLIT2-ROBO1 interaction, RNAi experi-
ments were performed. Three different siRNA oligonucleotides spe-
cifically against ROBO1 were designed for experiments. The mRNA
expression level of ROBO1 was measured 48 hours after transfect-
ed with ROBO1 siRNAs (Fig. S1B). After silencing ROBO1 expres-
sion, application of 100 ng/ml SLIT2-N in the cells no longer
affected cell migration. Similarly, ROBO1 knockdown did not affect
cell migration without SLIT2-N treatment (Fig. 5B), demonstrating
that effects of SLIT2 are mediated by the ROBO1 receptor. As both
miR-218-1 and SLIT2 were demonstrated as migration suppressors
in SH-SY5Y cells, we further aimed to determine whether the
migration inhibition was caused only by miR-218-1 or SLIT2-N or
both. Cells were treated with miR-218-1 mimics or SLIT2-N or
both. The results showed either miR-218-1 mimics or SLIT2-N
could suppress the migration ability of cells. Moreover, the combi-
nation of both enhanced the migration suppression compared with
miR-218-1 mimics or SLIT2-N alone (Fig. 5C), indicating miR-218-
1 together with SLIT2 play the pivotal roles in the progress of
HSCR.
Overexpressed miR-218-1 down-regulated
Ret and Plag1 resulting in the absence of
gangliocytes as well as the compensatory
hyperplasia of the nerve fibres in vivo
The transgenic mice were generated as presented in Figure S4.
Few mice in our study presented embryonic or post-natal lethality.
A
B
Fig. 3 Cytobiology change after treating cells with miR-218 mimics. (A) Transwell assay was performed as described in Materials and methods. The
representative images of invasive cells at the bottom of the membrane stained with crystal violet were visualized as shown (left). The quantifications
of cell migration were presented as percentage migrated cell numbers and the integrated intensity of migrated cells (right). * indicates significant
difference compared with control group (P < 0.05). (B) EDU assay was performed as described. The integrated density was presented with
mean  SE. * indicates significant difference compared with control group P < 0.05.
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The foetal gut was examined at E18.5. The haematoxylin and
eosin-stained sections of the hindgut in positive mice showed a
remarkable decrease in the gangliocytes which is an indicative of
roles of miR-218-1 in pathogenesis of HSCR. As the consequence
of the loss of ganglion cells, the nerve fibres were compensatory
proliferated (Fig. 6A). We also detected the ganglion cell of the
transgenic mice afterbirth. The defect we detected after birth kept
consist with the results of the mice during embryogenesis. Unfor-
tunately, the defect was not clearly visible as abdominal distension
or narrowed colon of mice, however, the ganglion cells was
decreased in the miR-218-1 transgenic mice compared with the
wild-type according to the results of the detailed stain of the
colon.
To further confirm the loss of gangliocytes, we performed the
immunohistochemistry assays to detect the expression of the biomar-
ker of gangliocytes (PGP9.5 and cathepsin D). Representative images
were shown in Figure 6B and C. The expression of both PGP9.5 and
cathepsin D were remarkably reduced compared with the wild-type
(Fig. S4C).
Furthermore, we detected the expression levels of Ret and Plag1
in the positive mice. As indicated in Figure 6D and E., both Ret and
Plag1 were down-regulated in the miR-218-1 transgenic mice. Collec-
tively, overexpression of miR-218-1 leads to the loss of ganglion cells
mediated by Ret and Plag1 in vivo.
Discussion
Hirschsprung’s disease is a common malformation condition of the
digestive tract in newborns. Aganglionosis attributes to the disorder
of the ENS whereby ganglion cells fail to innervate a variable length
of the gastrointestinal tract. The ENCCs which have a leading role in
the ENS colonization, are very important in the development of
HSCR. Derived from vagus nerve, the ENCCs move along the way
of the vagus nerves, enter the foregut mesenchyme, and spread in
a craniocaudal direction throughout the gastrointestinal tract [21].
In humans, the process takes about 7 weeks, with neural crest
derivatives entering the foregut at 5 weeks, reaching the distal
ileum by 7 weeks, the midcolon by 8 weeks, and taking a further
4 weeks to reach the distal rectum [22]. It is the longest journey
for cells reaching the distal rectum during embryogenesis. There-
fore, it is not surprising that any factor that affects proliferation,
survival, migration, or differentiation of ENCCs might result in agan-
glionosis.
Recently, a number of genes have been found to regulate ENCC
proliferation, migration and differentiation in HSCR including RET,
ASCL1 and HOXB5 [23, 24]. Consequently, the rostrocaudal migra-
tion of ENCCs along the long axis of the embryonic and foetal bowel
has been used as a model system to investigate the cellular and
molecular mechanisms underlying neural crest cell migration [25].
A
C D
B
Fig. 4 Up-regulated SLIT2/ROBO1 pathway played an important role in HSCR. (A) The genomic locations of miR-218-1 gene hosted in the intron 15
(274664–274773) of SLIT2. (B) Pearson correlation analysis was performed to evaluated the relationship between expression levels of SLIT2 mRNA
and miR-218-1 (data with natural log transformed), P = 0.0003, R = 0.34. (C) The expression levels of SLIT2 in human HSCR tissues and control
tissues as described above. * Significantly different compared with that of control (P < 0.05). (D) The proteins levels of SLIT2, ROBO1 in HSCR tis-
sues and control tissues were determined by Western blotting. Three representative samples from each group were shown. GAPDH was used as a
loading control.
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Fig. 6 Effects of miR-218-1 transgenic mice in vivo. (A) Haematoxylin and eosin staining was used to detect the phenotype alternation in the rectum
of miR-218-1 transgenic mice. Arrow in the left panel indicated the gangliocytes, the middle indicated the aganglionosis, while the right indicated
the compensatory proliferation of the nerve fibres. (B and C) Immunohistochemistry assays were conducted to detect the expression of the biomar-
ker of gangliocytes (PGP9.5 and cathepsin D). Arrow indicated positive staining of the proteins expressed in gangliocytes. (D and E) The mRNA and
protein expression level of Ret and Plag1 were examined in miR-218-1 transgenic mice and wild-type mice. All experiments were performed in tripli-
cate and presented as mean  SE. * indicates significant difference compared with control group (P < 0.05). * indicates remarkable difference
(P < 0.01).
Fig. 5 Overexpression of SLIT2 via SLIT2/ROBO1 pathway combining with miR-218-1 suppressed cell migration. (A) Transwell assay was performed
as described in Materials and methods. The representative images of invasive cells at the bottom of the membrane stained with crystal violet were
visualized as shown (left). The quantifications of cell migration were presented as percentage migrated cell numbers and the integrated intensity of
migrated cells (right). (B) Cells were treated with 100 ng/ml SLIT2-N, ROBO1 siRNA, SLIT2-N+ROBO1 siRNA and normal control for 48 hrs. The
representative images of invasive cells at the bottom of the membrane stained with crystal violet were visualized as shown (left). The quantifications
of cell migration were presented as the percentage of migrated cell numbers and the integrated intensity of migrated cells (right). (C) Cells were
treated with 100 ng/ml SLIT2-N, miR-218 mimics, SLIT2-N+ miR-218 mimics and normal control for 48 hrs. The representative images of invasive
cells at the bottom of the membrane stained with crystal violet were visualized as shown (left). The quantifications of cell migration were presented
as percentage migrated cell numbers and the integrated intensity of migrated cells (right). All experiments were performed in triplicate and pre-
sented as mean  SE. * indicates significant difference compared with control group (P < 0.05).
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RET, as one of the most important disease-related genes in HSCR,
has been reported to be markedly associated with cell migration. All
these studies suggest that alterations in cell proliferation and migra-
tion are crucial events in the pathogenesis of HSCR. In addition, the
expression level of RET has been proved highly associated with the
mutation of RET. In our study, the mutation of RET in patients was
also screened. The results indicated only two patients with c.352delC
mutation by using Illumina HumanExome Bead Chips (data not
shown). Thus, we thought that there might be other factors involved
in the down-regulation of RET.
The discovery of miRNAs provides a new layer of gene regulation,
which modulates complex physiological or disease phenotypes by
regulating entire functional networks. In this study, we used predic-
tion methods to find that miR-218-1 targets both RET and PLAG1. We
further validated these targets experimentally. Besides, the expression
of miR-218-1 was negatively correlated with RET and PLAG1 expres-
sion in HSCR tissue samples, suggesting a clinical implication. To
determine the functional relevance of miR-218-1, we performed cell
proliferation and migration assays in vitro. Our results showed that
miR-218-1 inhibited cell proliferation and migration via directly target-
ing RET and PLAG1. More importantly, we confirmed this pathway in
vivo. We also detected the ganglion cell of the transgenic mice after-
birth. The defect we detected after birth kept consist with the results
of the mice during embryogenesis. Unfortunately, the defect was not
clearly visible in the colon of mice afterbirth, however, the ganglion
cells was decreased in the miR-218-1 transgenic mice compared
with the wild-type according to the results of the detailed stain of
the colon. The miR-218-1 transgenic mice showed the remarkable
decrease in gangliocyte as well as the compensatory hyperplasia of
the nerve fibres. It has been reported that cells transfected with
siRNA of RET show an impaired ability of migration, while knock-
down of PLAG1 in mice could cause growth retardation and
reduced fertility [26]. Our result is consistent with those data.
SLIT2/ROBO1 signalling has been demonstrated to be angiogenic
under certain circumstances and SLIT2/ROBO1 interaction inhibits
cell migration and promotes cell death [27]. Here, we showed that
SLIT2-N, the functional subunit of SLIT2 suppressed cell migration,
whereas knockdown of ROBO1 reversed such inhibitory effect, sug-
gesting SLIT2/ROBO1 pathway is also involved in the pathogenesis of
HSCR. Moreover, overexpression of both miR-218-1 and SLIT2-N
achieved maximum migration suppression compared with, miR-218-
1 or SLIT2 alone; suggesting the progress of the disease is regulated
by multiple pathways.
MiR-218-1, acting as an important factor involved in the patho-
genesis of HSCR, might cause the decreased level of RET induced
the loss of the ganglion cells resulting in HSCR. Besides, the
down-regulation of PLAG1 was also associated with the aberrant
up-regulation of miR-218-1 which was related with the loss of
ganglion cells. In addition, SLIT2, the host gene of miR-218-1,
could also regulate the receptor ROBO1, reducing the migration of
ganglion cells. Taken together, this study reveals a novel mecha-
nism in the pathogenesis of HSCR (Fig. 7). Aberrant expression of
SLIT2 inhibits cell migration via ROBO1 as well as miR-218-1-
RET/PLAG1 pathway, which corporately contributes to the develop-
ment of HSCR disease. The new factors involved in this pathway
might be new targets for the early diagnosis or target therapy of
HSCR.
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recombinant SLIT2-N.
Fig. 7 Proposed mechanism underlying
pathogenesis of HSCR. Aberrant expres-
sion of SLIT2 inhibits cell migration via
ROBO1 as well as miR-218-1-RET/PLAG1
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